120 related articles for article (PubMed ID: 23548718)
1. Chlamydia trachomatis infections and subfertility: opportunities to translate host pathogen genomic data into public health.
Lal JA; Malogajski J; Verweij SP; de Boer P; Ambrosino E; Brand A; Ouburg S; Morré SA
Public Health Genomics; 2013; 16(1-2):50-61. PubMed ID: 23548718
[TBL] [Abstract][Full Text] [Related]
2. Do host genetic traits in the bacterial sensing system play a role in the development of Chlamydia trachomatis-associated tubal pathology in subfertile women?
den Hartog JE; Ouburg S; Land JA; Lyons JM; Ito JI; Peña AS; Morré SA
BMC Infect Dis; 2006 Jul; 6():122. PubMed ID: 16859562
[TBL] [Abstract][Full Text] [Related]
3. Chlamydia trachomatis-associated tubal factor subfertility: Immunogenetic aspects and serological screening.
den Hartog JE; Morré SA; Land JA
Hum Reprod Update; 2006; 12(6):719-30. PubMed ID: 16832042
[TBL] [Abstract][Full Text] [Related]
4. [Chlamydia antibody testing for tubal factor subfertility].
Lardenoije CM; Land JA
Ned Tijdschr Geneeskd; 2007 Sep; 151(36):1981-5. PubMed ID: 17953171
[TBL] [Abstract][Full Text] [Related]
5. Chlamydia antibody testing in subfertile women.
Land JA; den Hartog JE
Drugs Today (Barc); 2006 Mar; 42 Suppl A():35-42. PubMed ID: 16683042
[TBL] [Abstract][Full Text] [Related]
6. Serological markers of persistent C. trachomatis infections in women with tubal factor subfertility.
den Hartog JE; Land JA; Stassen FR; Kessels AG; Bruggeman CA
Hum Reprod; 2005 Apr; 20(4):986-90. PubMed ID: 15640255
[TBL] [Abstract][Full Text] [Related]
7. Potential protective effect of a G>A SNP in the 3'UTR of HLA-A for Chlamydia trachomatis symptomatology and severity of infection.
Jansen ME; Branković I; Spaargaren J; Ouburg S; Morré SA
Pathog Dis; 2016 Mar; 74(2):. PubMed ID: 26656886
[TBL] [Abstract][Full Text] [Related]
8. Chlamydia trachomatis IgG seropositivity is associated with lower natural conception rates in ovulatory subfertile women without visible tubal pathology.
Coppus SF; Land JA; Opmeer BC; Steures P; Eijkemans MJ; Hompes PG; Bossuyt PM; van der Veen F; Mol BW; van der Steeg JW
Hum Reprod; 2011 Nov; 26(11):3061-7. PubMed ID: 21926058
[TBL] [Abstract][Full Text] [Related]
9. Chlamydia trachomatis infection in fertile and subfertile women in Rwanda: prevalence and diagnostic significance of IgG and IgA antibodies testing.
Muvunyi CM; Dhont N; Verhelst R; Temmerman M; Claeys G; Padalko E
Hum Reprod; 2011 Dec; 26(12):3319-26. PubMed ID: 22016415
[TBL] [Abstract][Full Text] [Related]
10. Association of MICA gene polymorphisms with Chlamydia trachomatis infection and related tubal pathology in infertile women.
Mei B; Luo Q; Du K; Huo Z; Wang F; Yu P
Hum Reprod; 2009 Dec; 24(12):3090-5. PubMed ID: 19783834
[TBL] [Abstract][Full Text] [Related]
11. TLR2 haplotypes in the susceptibility to and severity of Chlamydia trachomatis infections in Dutch women.
Karimi O; Ouburg S; de Vries HJ; Peña AS; Pleijster J; Land JA; Morré SA
Drugs Today (Barc); 2009 Nov; 45 Suppl B():67-74. PubMed ID: 20011697
[TBL] [Abstract][Full Text] [Related]
12. Translational potential into health care of basic genomic and genetic findings for human immunodeficiency virus, Chlamydia trachomatis, and human papilloma virus.
Malogajski J; Brankovic I; Verweij SP; Ambrosino E; van Agtmael MA; Brand A; Ouburg S; Morré SA
Biomed Res Int; 2013; 2013():892106. PubMed ID: 23781508
[TBL] [Abstract][Full Text] [Related]
13. The role that the functional Asp299Gly polymorphism in the toll-like receptor-4 gene plays in susceptibility to Chlamydia trachomatis-associated tubal infertility.
Morré SA; Murillo LS; Bruggeman CA; Peña AS
J Infect Dis; 2003 Jan; 187(2):341-2; author reply 342-3. PubMed ID: 12552467
[No Abstract] [Full Text] [Related]
14. Chlamydia serology screening in infertility patients.
Keltz MD; Gera PS; Moustakis M
Fertil Steril; 2006 Mar; 85(3):752-4. PubMed ID: 16500355
[TBL] [Abstract][Full Text] [Related]
15. TLR4 in Chlamydia trachomatis infections: knockout mice, STD patients and women with tubal factor subfertility.
den Hartog JE; Lyons JM; Ouburg S; Fennema JS; de Vries HJ; Bruggeman CA; Ito JI; Peña AS; Land JA; Morré SA
Drugs Today (Barc); 2009 Nov; 45 Suppl B():75-82. PubMed ID: 20011698
[TBL] [Abstract][Full Text] [Related]
16. Multiple site sampling does not increase the sensitivity of Chlamydia trachomatis detection in infertility patients.
Dietrich W; Rath M; Stanek G; Apfalter P; Huber JC; Tempfer C
Fertil Steril; 2010 Jan; 93(1):68-71. PubMed ID: 18990379
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of an indirect immunofluorescence assay for detecting Chlamydia trachomatis as a method for diagnosing tubal factor infertility in Mexican women.
Guerra-Infante FM; Carballo-Perea R; Zamora-Ruiz A; López-Hurtado M; Flores-Medina S; Contreras GM
Int J Fertil Womens Med; 2003; 48(2):74-82. PubMed ID: 12779293
[TBL] [Abstract][Full Text] [Related]
18. The Potential Role for Host Genetic Profiling in Screening for Chlamydia-Associated Tubal Factor Infertility (TFI)-New Perspectives.
Malogajski J; Branković I; Land JA; Thomas PPM; Morré SA; Ambrosino E
Genes (Basel); 2019 May; 10(6):. PubMed ID: 31142036
[TBL] [Abstract][Full Text] [Related]
19. The predictive value of medical history taking and Chlamydia IgG ELISA antibody testing (CAT) in the selection of subfertile women for diagnostic laparoscopy: a clinical prediction model approach.
Coppus SF; Opmeer BC; Logan S; van der Veen F; Bhattacharya S; Mol BW
Hum Reprod; 2007 May; 22(5):1353-8. PubMed ID: 17234674
[TBL] [Abstract][Full Text] [Related]
20. Tubal factor pathology caused by Chlamydia trachomatis: the role of serology.
Mouton JW; Peeters MF; van Rijssort-Vos JH; Verkooyen RP
Int J STD AIDS; 2002 Dec; 13 Suppl 2():26-9. PubMed ID: 12537722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
